Sandwich, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of cancer therapeutics designed to treat solid tumors. Ottimo Pharma is based in Sandwich, United Kingdom and was founded in 2017. Its last reported valuation was $242 million in Dec 2024. It has raised $150 million.
Last reported valuation
$242.4M
Oct 2026
Priced at
—
Total raised
$149.7M
Last round
—
Team — not yet on record
No current team members for Ottimo Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ottimo Pharma with a free account
·The complete investor list: 11 names
·Watch Ottimo Pharma: the Monday email on marks, rounds and moves
